Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15,869 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimal management of lenvatinib therapy for patients with unresectable hepatocellular carcinoma by balancing the therapeutic effect with the relative dose intensity.
Tokunaga T, Tateyama M, Tanaka K, Narahara S, Inada H, Kurano S, Hayashi S, Yoshimaru Y, Nagaoka K, Watanabe T, Setoyama H, Tanaka M, Tanaka Y. Tokunaga T, et al. Among authors: watanabe t. Hepatol Res. 2022 Jan;52(1):105-119. doi: 10.1111/hepr.13720. Epub 2021 Oct 22. Hepatol Res. 2022. PMID: 34626450
Evaluation of sorafenib treatment and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a comparative study using the propensity score matching method.
Fukubayashi K, Tanaka M, Izumi K, Watanabe T, Fujie S, Kawasaki T, Yoshimaru Y, Tateyama M, Setoyama H, Naoe H, Kikuchi K, Sasaki Y. Fukubayashi K, et al. Among authors: watanabe t. Cancer Med. 2015 Aug;4(8):1214-23. doi: 10.1002/cam4.476. Epub 2015 Jun 4. Cancer Med. 2015. PMID: 26044168 Free PMC article.
Ledipasvir and sofosbuvir for recurrent hepatitis C after liver transplantation.
Oya Y, Sugawara Y, Watanabe T, Yoshimaru Y, Honda M, Hashimoto S, Yoshii D, Isono K, Hayashida S, Yamamoto H, Tanaka M, Sasaki Y, Inomata Y. Oya Y, et al. Among authors: watanabe t. Biosci Trends. 2017 Jan 16;10(6):496-499. doi: 10.5582/bst.2016.01223. Epub 2016 Dec 18. Biosci Trends. 2017. PMID: 27990005 Free article. Clinical Trial.
Modeling of the Weight Status and Risk of Nonalcoholic Fatty Liver Disease in Elderly Individuals: The Potential Impact of the Disulfide Bond-Forming Oxidoreductase A-Like Protein (DsbA-L) Polymorphism on the Weight Status.
Oniki K, Watanabe T, Kudo M, Izuka T, Ono T, Matsuda K, Sakamoto Y, Nagaoka K, Imafuku T, Ishima Y, Watanabe H, Maruyama T, Otake K, Ogata Y, Saruwatari J. Oniki K, et al. Among authors: watanabe t, watanabe h. CPT Pharmacometrics Syst Pharmacol. 2018 Jun;7(6):384-393. doi: 10.1002/psp4.12292. Epub 2018 Mar 30. CPT Pharmacometrics Syst Pharmacol. 2018. PMID: 29569850 Free PMC article.
Murine neonatal ketogenesis preserves mitochondrial energetics by preventing protein hyperacetylation.
Arima Y, Nakagawa Y, Takeo T, Ishida T, Yamada T, Hino S, Nakao M, Hanada S, Umemoto T, Suda T, Sakuma T, Yamamoto T, Watanabe T, Nagaoka K, Tanaka Y, Kawamura YK, Tonami K, Kurihara H, Sato Y, Yamagata K, Nakamura T, Araki S, Yamamoto E, Izumiya Y, Sakamoto K, Kaikita K, Matsushita K, Nishiyama K, Nakagata N, Tsujita K. Arima Y, et al. Among authors: watanabe t. Nat Metab. 2021 Feb;3(2):196-210. doi: 10.1038/s42255-021-00342-6. Epub 2021 Feb 18. Nat Metab. 2021. PMID: 33619377
Modified albumin-bilirubin grade to predict eligibility for second-line therapies at progression on sorafenib therapy in hepatocellular carcinoma patients.
Tokunaga T, Tanaka M, Tanaka K, Narahara S, Kawasaki T, Yoshimaru Y, Nagaoka K, Watanabe T, Tateyama M, Naoe H, Sasaki Y, Tanaka Y. Tokunaga T, et al. Among authors: watanabe t. Int J Clin Oncol. 2021 May;26(5):922-932. doi: 10.1007/s10147-020-01835-2. Epub 2021 Mar 17. Int J Clin Oncol. 2021. PMID: 33730200
15,869 results
You have reached the last available page of results. Please see the User Guide for more information.